BioMarin Says It&39;s Got The Hemophilia Therapy Data For Approval And Value

BioMarin Says It's Got The Hemophilia Therapy Data For Approval And Value

14:28 EDT 28 May 2019 | SCRIP

The company will begin discussions with regulators in the US and Europe for a gene therapy for hemophilia A based...